MS, S.; MANJUNATH; PL, B.; KN, R.; MUKESH. A Prospective Randomised Open Label Study to Evaluate the Response Rate and Toxicity of Gefitinib in the Treatment of Carcinoma Cervix Patients on Chemoradiotherapy. Journal of Clinical Research and Applied Medicine, [S. l.], v. 1, n. 2, p. 59–62, 2022. DOI: 10.5530/jcram.1.2.14. Disponível em: https://jcramonline.com/index.php/jcram/article/view/14. Acesso em: 28 apr. 2024.